Medical technology firms Abbott Laboratories and Stryker announced separate acquisitions with a combined value of $8.6 billion, aiming to further expand their portfolios beyond implanted devices and appeal to hospitals and clinics looking to bring down costs.
from WSJ.com: US Business http://ift.tt/1UEhhJT
via IFTTT
No comments:
Post a Comment